TVGN
NASDAQ
$3.89
Tevogen Bio Holdings Inc (TVGN)
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. The company is headquartered in Warren, New Jersey.
Sector:
Healthcare
Industry:
Biotechnology
Target: $2 (-48.59%)
Market Cap
$20M
Free Cash Flow Yield
-59.31%
Beta (5Y)
1.44
Price Chart
Valuation
Market Cap$20M
Profitability
EBITDA-$21M
EPS-$5.34
Financial Health
Free Cash Flow Yield-59.31%
Growth & Risk
Beta (5Y)1.44
Sharpe Ratio-1.98